Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial.
- 2019-05-28
- Beneficial Microbes 10(5)
- Y. Kobayashi
- T. Kuhara
- M. Oki
- J.‐Z. Xiao
- PubMed: 31090457
- DOI: 10.3920/BM2018.0170
Abstract
In our previous study, we reported the therapeutic potential of Bifidobacterium breve A1 in preventing cognitive impairment in a mouse model of Alzheimer's disease and participants with mild cognitive impairment; we suggested that probiotic supplementation is an effective therapeutic strategy for managing cognitive function. Accordingly, we conducted a randomised, double-blind, placebo-controlled trial to assess whether 12-week B. breve A1 supplementation could affect the cognitive function of elderly subjects with memory complaints. We assessed cognitive function using the Japanese version of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Mini-Mental State Examination (MMSE) at baseline and after 12 weeks of probiotic supplementation. A total of 121 participants were randomised and received B. breve A1 capsules or placebo daily for 12 weeks; of these, 117 participants completed the study. At 12 weeks, neuropsychological test scores significantly increased in both groups; no significant intergroup difference was observed in terms of changes in scores from the baseline scores. However, a stratified analysis revealed a significant difference between B. breve A1 and placebo groups in terms of the subscale 'immediate memory' of RBANS and MMSE total score in the subjects with low RBANS total score at baseline. No significant differences in terms of blood parameters between the groups or adverse effects caused by B. breve A1 intervention were observed. The results of the present study suggest the safety of B. breve A1 supplementation and its potential in maintaining cognitive function in elderly subjects with memory complaints. However, future large-scale studies on individuals with impaired cognitive function are required to validate the present findings.
Keywords: cognitive function; mild cognitive impairment; probiotic supplementation.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bifidobacterium breve | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve | No Significant Cognitive Improvement | Neutral | Small |
Bifidobacterium breve Bb-03 | Improved Cognitive Function | Beneficial | Small |
Bifidobacterium breve BBr60 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve Bbr8 | Improved Cognitive Function | Beneficial | Small |
Bifidobacterium breve Bbr8 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve Bbr8 | No Adverse Health Effects | Neutral | Large |
Bifidobacterium breve Bbr8 | No Significant Cognitive Improvement | Neutral | Small |
Bifidobacterium breve BR-03 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve BR-03 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve BR03 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve BR03 | Improved MMSE Score | Beneficial | Moderate |
Bifidobacterium breve BR03 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve BR03 | No Difference in Overall Cognitive Scores | Neutral | Small |
Bifidobacterium breve IDCC 4401 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve IDCC 4401 | Improved MMSE Score | Beneficial | Moderate |
Bifidobacterium breve IDCC 4401 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve IDCC 4401 | No Adverse Health Effects | Neutral | Large |
Bifidobacterium breve MAK40B22B | Improved Cognitive Function | Beneficial | Small |
Bifidobacterium breve R0070 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve R0070 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve Rosell-70 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve Rosell-70 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve SD5206 | Improved Cognitive Function | Beneficial | Small |
Bifidobacterium breve SD5206 | Safety of Probiotic Supplementation | Neutral | Moderate |
Bifidobacterium breve UABbr-11 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve UABbr-11 | Maintained Cognitive Function | Beneficial | Small |
Bifidobacterium breve VPro 52 | Improved Immediate Memory | Beneficial | Moderate |
Bifidobacterium breve VPro 52 | Maintained or Improved Cognitive Function | Beneficial | Moderate |